tetano
Editor, Senior Moderator
Crit Care Explor
. 2020 Nov 11;2(11):e0244.
doi: 10.1097/CCE.0000000000000244. eCollection 2020 Nov.
Risk Factors for Invasive Pulmonary Aspergillosis in Critically Ill Patients With Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome
Paul Chauvet[SUP] 1 [/SUP], Jihad Mallat[SUP] 2 [/SUP], Clothilde Arumadura[SUP] 1 [/SUP], Nicolas Vangrunderbeek[SUP] 1 [/SUP], C?line Dupre[SUP] 1 [/SUP], Philippe Pauquet[SUP] 1 [/SUP], Annis Orfi[SUP] 1 [/SUP], Maxime Granier[SUP] 1 [/SUP], Malcolm Lemyze[SUP] 1 [/SUP]
Affiliations
Abstract
Severe coronavirus disease 2019 pneumonia can lead to acute respiratory distress syndrome. Recently, several publications reported on coronavirus disease 2019-associated pulmonary aspergillosis. However, risk factors remain unclear. We retrospectively collected all the cases of coronavirus disease 2019 acute respiratory distress syndrome patients (n = 46) admitted to our 34-bed ICU between March 24, 2020, and May 25, 2020, and identified six patients that met the diagnosis of invasive pulmonary aspergillosis according to previously established definitions. This population exhibited higher severity scores at admission and less hospital discharge compared with noninvasive pulmonary aspergillosis patients. Chronic obstructive pulmonary disease, malnutrition, and systemic corticosteroid use were identified as risk factors for invasive pulmonary aspergillosis in coronavirus disease 2019-induced acute respiratory distress syndrome patients. Coronavirus disease 2019-associated pulmonary aspergillosis may be a serious concern regarding corticosteroids use to control the inflammatory response of coronavirus disease 2019-induced acute respiratory distress syndrome.
Keywords: acute respiratory distress syndrome; aspergillus; coronavirus; coronavirus disease 2019; invasive pulmonary aspergillosis; systemic corticosteroids.
. 2020 Nov 11;2(11):e0244.
doi: 10.1097/CCE.0000000000000244. eCollection 2020 Nov.
Risk Factors for Invasive Pulmonary Aspergillosis in Critically Ill Patients With Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome
Paul Chauvet[SUP] 1 [/SUP], Jihad Mallat[SUP] 2 [/SUP], Clothilde Arumadura[SUP] 1 [/SUP], Nicolas Vangrunderbeek[SUP] 1 [/SUP], C?line Dupre[SUP] 1 [/SUP], Philippe Pauquet[SUP] 1 [/SUP], Annis Orfi[SUP] 1 [/SUP], Maxime Granier[SUP] 1 [/SUP], Malcolm Lemyze[SUP] 1 [/SUP]
Affiliations
- PMID: 33205046
- PMCID: PMC7665250
- DOI: 10.1097/CCE.0000000000000244
Abstract
Severe coronavirus disease 2019 pneumonia can lead to acute respiratory distress syndrome. Recently, several publications reported on coronavirus disease 2019-associated pulmonary aspergillosis. However, risk factors remain unclear. We retrospectively collected all the cases of coronavirus disease 2019 acute respiratory distress syndrome patients (n = 46) admitted to our 34-bed ICU between March 24, 2020, and May 25, 2020, and identified six patients that met the diagnosis of invasive pulmonary aspergillosis according to previously established definitions. This population exhibited higher severity scores at admission and less hospital discharge compared with noninvasive pulmonary aspergillosis patients. Chronic obstructive pulmonary disease, malnutrition, and systemic corticosteroid use were identified as risk factors for invasive pulmonary aspergillosis in coronavirus disease 2019-induced acute respiratory distress syndrome patients. Coronavirus disease 2019-associated pulmonary aspergillosis may be a serious concern regarding corticosteroids use to control the inflammatory response of coronavirus disease 2019-induced acute respiratory distress syndrome.
Keywords: acute respiratory distress syndrome; aspergillus; coronavirus; coronavirus disease 2019; invasive pulmonary aspergillosis; systemic corticosteroids.